Abstract
Microbes produce a wide range of molecules that can modulate eukaryotic immune responses. These include factors that subvert protective mechanisms in order to facilitate pathogen colonization and persistence. Viral, bacterial and parasite-derived molecules have been identified that can inhibit inflammatory responses. However, in addition to the plethora of microbial factors that suppress immune responses, the most potent immune activators are also of microbial origin. These include the bacterial enterotoxins, parasite-derived excretory-secretory products and viral nucleic acids. In fact, there are examples of immune modulators that can exert either stimulatory or suppressive effects depending on the mode of delivery, dose and experimental model. There is presently great interest in the therapeutic exploitation of these factors, for example as a means to stimulate enhanced immune responses to a new generation of subunit vaccines or to inhibit deleterious immune mediated diseases. This short review, describes representative microbial immunomodulators, their modes of action and the potential for therapeutic application.
Keywords: Immunomodulatory Drugs, enterotoxins, immune responses
Current Topics in Medicinal Chemistry
Title: Molecules of Infectious Agents as Immunomodulatory Drugs
Volume: 4 Issue: 5
Author(s): Ed C. Lavelle, Peter McGuirk and Kingston H.G. Mills
Affiliation:
Keywords: Immunomodulatory Drugs, enterotoxins, immune responses
Abstract: Microbes produce a wide range of molecules that can modulate eukaryotic immune responses. These include factors that subvert protective mechanisms in order to facilitate pathogen colonization and persistence. Viral, bacterial and parasite-derived molecules have been identified that can inhibit inflammatory responses. However, in addition to the plethora of microbial factors that suppress immune responses, the most potent immune activators are also of microbial origin. These include the bacterial enterotoxins, parasite-derived excretory-secretory products and viral nucleic acids. In fact, there are examples of immune modulators that can exert either stimulatory or suppressive effects depending on the mode of delivery, dose and experimental model. There is presently great interest in the therapeutic exploitation of these factors, for example as a means to stimulate enhanced immune responses to a new generation of subunit vaccines or to inhibit deleterious immune mediated diseases. This short review, describes representative microbial immunomodulators, their modes of action and the potential for therapeutic application.
Export Options
About this article
Cite this article as:
Lavelle C. Ed, McGuirk Peter and Mills H.G. Kingston, Molecules of Infectious Agents as Immunomodulatory Drugs, Current Topics in Medicinal Chemistry 2004; 4 (5) . https://dx.doi.org/10.2174/1568026043451249
DOI https://dx.doi.org/10.2174/1568026043451249 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |
Call for Papers in Thematic Issues
Chemistry Based on Natural Products for Therapeutic Purposes
The development of new pharmaceuticals for a wide range of medical conditions has long relied on the identification of promising natural products (NPs). There are over sixty percent of cancer, infectious illness, and CNS disease medications that include an NP pharmacophore, according to the Food and Drug Administration. Since NP ...read more
Current Trends in Drug Discovery Based on Artificial Intelligence and Computer-Aided Drug Design
Drug development discovery has faced several challenges over the years. In fact, the evolution of classical approaches to modern methods using computational methods, or Computer-Aided Drug Design (CADD), has shown promising and essential results in any drug discovery campaign. Among these methods, molecular docking is one of the most notable ...read more
Drug Discovery in the Age of Artificial Intelligence
In the age of artificial intelligence (AI), we have witnessed a significant boom in AI techniques for drug discovery. AI techniques are increasingly integrated and accelerating the drug discovery process. These developments have not only attracted the attention of academia and industry but also raised important questions regarding the selection ...read more
From Biodiversity to Chemical Diversity: Focus of Flavonoids
Flavonoids are the largest group of polyphenols, plant secondary metabolites arising from the essential aromatic amino acid phenylalanine (or more rarely from tyrosine) via the phenylpropanoid pathway. The flavan nucleus is the basic 15-carbon skeleton of flavonoids (C6-C3-C6), which consists of two phenyl rings (A and B) and a heterocyclic ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Multimodality Imaging in Acute Ischemic Stroke
Current Medical Imaging Inflammatory Mediators in Epilepsy
Current Pharmaceutical Design Inhibitors of Cholinesterases in Pharmacology: the Current Trends
Mini-Reviews in Medicinal Chemistry Natural Products: A Rich Source of Antiviral Drug Lead Candidates for the Management of COVID-19
Current Pharmaceutical Design Anti-Inflammatory Drugs in Psychiatry
Inflammation & Allergy - Drug Targets (Discontinued) New Perspectives in HCV Therapy: Entry Inhibitors
Recent Patents on Anti-Infective Drug Discovery Crystallization and Preliminary Crystallographic Analysis of Allograft Inflammatory Factor 1
Protein & Peptide Letters Arboviral Encephalitis and RNAi Treatment
Central Nervous System Agents in Medicinal Chemistry Bipolar Affective Disorder, Epilepsy and Migraine – Does Possible Shared Pathogenesis Explain their Association?
Current Psychopharmacology HIV-1 Induced CNS Dysfunction: Current Overview and Research Priorities
Current HIV Research Solving the Blood-Brain Barrier Challenge for the Effective Treatment of HIV Replication in the Central Nervous System
Current Pharmaceutical Design Substance Abuse, HIV-1 and Hepatitis
Current HIV Research Neurobrucellosis: A Case Report with an Unusual Presentation
Recent Advances in Anti-Infective Drug Discovery VEGF/VEGFR Pathway Inhibitors as Anti-Angiogenic Agents: Present and Future
Current Cancer Drug Targets Molecular Approach to Targeted Therapy for Multiple Sclerosis
CNS & Neurological Disorders - Drug Targets Neurotrophic Factors in the Pathogenesis of Neurological Disorders with Mental Retardation in Children
Current Pediatric Reviews Ex Vivo Liver – Directed Gene Therapy for the Treatment of Metabolic Diseases: Advances in Hepatocyte Transplantation and Retroviral Vectors
Current Gene Therapy The Induction of Proinflammatory Cytokines in Response to Avian Influenza H5N1 Infections and their Role in Pathogenesis and the Enhancement of Virulence
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Status Epilepticus: An Overview
Current Drug Metabolism Microbes, Immunity and Multiple Sclerosis: An Update
Current Immunology Reviews (Discontinued)